SL
RVMD icon

Siren LLC’s Revolution Medicines RVMD Stock Holding History

Siren LLC’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$169M Sell
900,000
-210,980
-19% -$30.8M 3.41% 6
2026
Q1 		$108M Sell
1,110,980
-224,095
-17% -$22.6M 3% 8
2025
Q4 		$106M Buy
1,335,075
+291,355
+28% +$19.1M 3.17% 5
2025
Q3 		$48.7M Buy
1,043,720
+104,965
+11% +$4.11M 1.91% 17
2025
Q2 		$34.5M Buy
938,755
+375,000
+67% +$14.4M 1.79% 18
2025
Q1 		$19.9M Sell
563,755
-7,793
-1% -$316K 1.12% 23
2024
Q4 		$25M Sell
571,548
-182,053
-24% -$9.19M 1.1% 26
2024
Q3 		$34.2M Buy
+753,601
New +$32.8M 1.71% 21

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Siren LLC's RVMD Position: Q2 2026 in Review

Siren LLC reduced its Revolution Medicines (RVMD) stake by 19% in Q2 2026, selling an estimated $30.8M and leaving 900,000 shares worth $169M. The position accounts for 3.41% of the portfolio, ranked #6.

Siren LLC first reported a position in RVMD in Q3 2024 and has held it in 8 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Siren LLC held 900,000 shares of Revolution Medicines worth $169M as of Q2 2026.
  • Siren LLC sold 210,980 Revolution Medicines shares in Q2 2026, an estimated $30.8M.
  • Revolution Medicines made up 3.41% of Siren LLC's portfolio in Q2 2026, its #6 holding.
  • Siren LLC first reported a position in Revolution Medicines in Q3 2024 and has held it in 8 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Siren LLC's 13F filing for Q2 2026, filed 13 Aug 2026.